Evidence map›Paper›PMID 24891766›Full record

ArticleMediators of inflammation2014

Lycopene modulates THP1 and Caco2 cells inflammatory state through transcriptional and nontranscriptional processes.

Njock Makon-Sébastien, Fouchier Francis, Seree Eric, Villard Pierre Henri, Landrier Jean François, Pechere Laurent, Barra Yves, Champion Serge

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Lycopene from Red Guava (Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Njock Makon-SébastienLaboratoire de Génie Génétique, Faculté de Pharmacie, Aix-Marseille Université, 27 boulevard Jean Moulin, 13385 Marseille, France ; Advanced Diagnostics, Toronto General Research Institute, University Health Network, 101 College Street, TMDT, Rm. 3-301, Toronto, ON, Canada M5G 1L7.
Fouchier FrancisLaboratoire de Génie Génétique, Faculté de Pharmacie, Aix-Marseille Université, 27 boulevard Jean Moulin, 13385 Marseille, France.
Seree EricINRA, UMR1260/1062 INSERM/AMU, Nutrition, Obésité et Risque Thrombotique, 27 boulevard Jean Moulin, 13385 Marseille, France ; Laboratoire de Génie Génétique, INRA 1260, Faculté de Pharmacie, 27 boulevard Jean Moulin, 13385 Marseille Cedex 5, France.
Villard Pierre HenriIMBE-UMR CNRS 7263/IRD 237, Mutagenèse Environnementale, Faculté de Pharmacie, Aix-Marseille Université, 27 boulevard Jean Moulin, 13385 Marseille, France.
Landrier Jean FrançoisINRA, UMR1260/1062 INSERM/AMU, Nutrition, Obésité et Risque Thrombotique, 27 boulevard Jean Moulin, 13385 Marseille, France.
Pechere LaurentLaboratoires YVERY, 134 rue Edmond Rostand, 13008 Marseille, France.
Barra YvesLaboratoire de Génie Génétique, Faculté de Pharmacie, Aix-Marseille Université, 27 boulevard Jean Moulin, 13385 Marseille, France.
Champion SergeIMBE-UMR CNRS 7263/IRD 237, Mutagenèse Environnementale, Faculté de Pharmacie, Aix-Marseille Université, 27 boulevard Jean Moulin, 13385 Marseille, France.
Aix-Marseille Université · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut de Recherche pour le Développement · FRNutrition, Obésité et Risque Thrombotique · FRUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We revisited the action of a carotenoid, the lycopene, on the expression of proinflammatory genes, reactive oxygen species (ROS) production, and metalloprotease (MMP9) activity. THP1 and Caco2 cell lines were used as in vitro models for the two main cell types found in intestine tissue, that is, monocytes and epithelial cells. Proinflammatory condition was induced using either phorbol ester acetate (PMA), lipopolysaccharide (LPS) or tumor necrosis factor (TNF). In THP1 cells, short term pretreatment (2 h) with a low concentration (2 μM) of lycopene reinforce proinflammatory gene expression. The extent of the effect of lycopene is dependent on the proinflammtory stimulus (PMA, LPS or TNF) used. Lycopene enhanced MMP9 secretion via a c-AMP-dependent process, and reduced ROS production at higher concentrations than 2 μM. Cell culture media, conditioned by PMA-treated monocytes and then transferred on CaCo-2 epithelial cells, induced a proinflammatory state in these cells. The extent of this inflammatory effect was reduced when cells has been pretreated (12 h) with lycopene. At low concentration (2 μM or less), lycopene appeared to promote an inflammatory state not correlated with ROS modulation. At higher concentration (5 μM-20 μM), an anti-inflammatory effect takes place as a decrease of ROS production was detected. So, both concentration and time have to be considered in order to define the exact issue of the effect of carotenoids present in meals.

Indexed as

Gene Expression RegulationTranscription, GeneticAntioxidantsbeta-GalactosidaseCaco-2 CellsCarotenoidsCell LineCyclic AMPGene Expression ProfilingHumansInflammationLipopolysaccharidesLycopeneMatrix Metalloproteinase 9MonocytesReactive Oxygen SpeciesAntioxidantsbeta-GalactosidaseCarotenoidsCyclic AMPLipopolysaccharidesLycopeneMatrix Metalloproteinase 9MMP9 protein, humanReactive Oxygen SpeciesTetradecanoylphorbol AcetateTumor Necrosis Factor-alpha

Identifiers

PMID24891766
PMCPMC4033542
OpenAlexW2141139492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.